[Clinical pharmacological medication reviews]
Mikkel Bring Christensen1,2, Marlene Lunddal Krogh3,4, David Peick Sonne1,2
1Klinisk Farmakologisk Afdeling, Københavns Universitetshospital - Bispebjerg og Frederiksberg Hospital.
Ugeskrift for Laeger
|April 13, 2026
Summary
Medication reviews in Denmark require a multidisciplinary approach led by general practice. National guidelines and the Danish Society for Clinical Pharmacology emphasize standardized clinical pharmacological medication reviews across all regions.
Area of Science:
- Clinical Pharmacy
- Pharmacology
- Health Services Research
Background:
- Medication reviews are recommended by Danish national guidelines.
- There is a need for a shared understanding of medication review scope and content.
- General practice plays a key role in medication reviews.
Purpose of the Study:
- To review the current state of medication reviews in Denmark.
- To highlight the importance of a cross-sectoral, multidisciplinary approach.
- To present the framework for clinical pharmacological medication reviews.
Main Methods:
- Literature review of Danish national guidelines.
- Analysis of recommendations regarding medication reviews.
- Examination of the framework defined by the Danish Society of Clinical Pharmacology.
Main Results:
- Several Danish national guidelines recommend medication reviews.
- A framework for »clinical pharmacological medication review« has been defined.
- These reviews are offered as advisory services in all Danish regions.
Conclusions:
- Medication reviews in Denmark should be a cross-sectoral, multidisciplinary effort.
- General practice should anchor the responsibility for medication reviews.
- Standardized clinical pharmacological medication reviews are essential for patient care.
More Related Videos
05:10Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.3K
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
3.1K
Related Concept Videos
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
85
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
85
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
339
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
339
01:26Drug Administration and Therapy Phases: Overview
2.0K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
2.0K
01:15Drug Dosing: Geriatric Patients
368
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
368
01:25Drug Regulation
3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K